CITIGROUP INC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$3,805,255
-1.4%
906,013
+41.1%
0.00%0.0%
Q4 2022$3,859,147
-33.0%
642,121
-35.1%
0.00%
-25.0%
Q3 2022$5,759,000
+118.3%
989,446
+123.9%
0.00%
+100.0%
Q2 2022$2,638,000
+585.2%
441,843
+436.1%
0.00%
Q1 2022$385,00082,418
+2747166.7%
0.00%
Q2 2021$0
-100.0%
3
-100.0%
0.00%
Q1 2021$77,000
-1.3%
26,563
+10.0%
0.00%
Q4 2020$78,00024,144
+804700.0%
0.00%
Q3 2020$030.0%0.00%
Q2 2020$03
-87.0%
0.00%
Q1 2020$0230.0%0.00%
Q4 2019$0
-100.0%
23
-99.6%
0.00%
Q3 2019$5,000
-28.6%
5,784
-25.2%
0.00%
Q2 2019$7,000
-50.0%
7,734
-44.2%
0.00%
Q1 2019$14,000
+40.0%
13,870
+2.2%
0.00%
Q4 2018$10,000
-69.7%
13,578
-12.0%
0.00%
Q3 2018$33,000
-13.2%
15,426
+106.6%
0.00%
Q2 2018$38,0007,465
+5824.6%
0.00%
Q1 2018$0126
+18.9%
0.00%
Q4 2017$0106
-15.9%
0.00%
Q3 2017$01260.0%0.00%
Q2 2017$01260.0%0.00%
Q1 2017$01260.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders